Project Number 5R01AG073482-02 Agency/Funding Organization NIA Funding Year 2022 View Full Project Details for Veri-T: A phase 1 Placebo-Controlled Trial of Verdiperstat in Semantic Variant Primary Progressive Aphasia Due to Underlying FTLD-TDP Research Categorization Primary Disease / Condition Frontotemporal Dementia CADRO Category C. Translational Research and Clinical Interventions 7. Early-stage Clinical Drug Development (Phase I and II Clinical Trials) g. Oxidative Stress Researcher and Organization Principal Investigator LJUBENKOV, PETER ALEXANDER Principal Investigator First Name PETER ALEXANDER Principal Investigator Last Name LJUBENKOV Awardee Organization University of California San Francisco Awardee State California Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-18-877: Early Stage Clinical Trials for the Spectrum of Alzheimers Disease and Age-related Cognitive Decline (R01 Clinical Trial Optional) FY Overall Cost $640,216 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official CLARKE, AKANNI YAO
